Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Payables (2020 - 2025)

Historic Payables for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • MDxHealth's Payables fell 959.08% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 959.08%. This contributed to the annual value of $8.0 million for FY2024, which is 919.31% down from last year.
  • Latest data reveals that MDxHealth reported Payables of $9.4 million as of Q3 2025, which was down 959.08% from $7.7 billion recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Payables ranged from a high of $7.7 billion in Q2 2025 and a low of $7.5 million during Q4 2021
  • In the last 5 years, MDxHealth's Payables had a median value of $9.6 million in 2022 and averaged $555.6 million.
  • As far as peak fluctuations go, MDxHealth's Payables tumbled by 2555.95% in 2023, and later skyrocketed by 6302056.74% in 2025.
  • Over the past 5 years, MDxHealth's Payables (Quarter) stood at $7.5 million in 2021, then surged by 36.53% to $10.2 million in 2022, then dropped by 13.43% to $8.8 million in 2023, then decreased by 9.19% to $8.0 million in 2024, then rose by 17.35% to $9.4 million in 2025.
  • Its Payables stands at $9.4 million for Q3 2025, versus $7.7 billion for Q2 2025 and $7.6 million for Q1 2025.